News
Cadila Pharma eyes South-East Asia expansion through Wellesta Alliance
The proposed joint venture will accelerate the launch of pharmaceutical and consumer healthcare products across South-East Asia, the Middle East, <a href="https://absafricatv.com/elon-musk-claims-africa-deaths-fell-after-us-aid-cuts/” title=”Elon Musk claims Africa deaths fell after US aid cuts”>Africa, and other emerging markets
Cadila Pharmaceuticals and Wellesta Holdings Pte. Ltd. have signed a Memorandum of Understanding (MoU) to establish a strategic joint venture aimed at expanding access to high-quality pharmaceutical and healthcare solutions across South-East Asia and selected international markets
The partnership will leverage Cadila Pharmaceuticals’ strengths in research and development, manufacturing, regulatory compliance, and its broad portfolio of prescription medicines, consumer healthcare products, and specialty therapies.Â
Wellesta Holdings will contribute its established commercialization infrastructure, regulatory expertise, market access capabilities, distribution network, and commercial presence across South-East Asia and other international markets
The proposed joint venture will focus on identifying, developing, and commercializing high-potential pharmaceutical and healthcare products by combining Cadila’s innovation and manufacturing capabilities with Wellesta’s regional market expertise.Â
The collaboration is expected to strengthen Cadila’s footprint in key growth markets while expanding Wellesta’s portfolio with differentiated healthcare offerings
Beyond South-East Asia, the joint venture is envisioned as a long-term growth platform targeting expansion across the Middle East, Africa, and other emerging markets.Â
Both companies said the collaboration reflects their shared commitment to improving healthcare access through innovation, quality, and strong commercial execution while creating long-term value for patients, healthcare professionals, and stakeholders
Upcoming E-conference
Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma
July 17, 2026Register Now
Other Related stories
ZeeLab Pharmacy launches iOS app to expand affordable digital healthcare access
CORONA Remedies commissions EU-GMP approved hormone manufacturing facility in Ahmedabad
Strides Pharma divests majority stake in Pivot Path for Rs. 100 Cr
View More
Interviews
Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head – API Regulatory Sciences, Biocon Limited
Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
View More
Appointments
<img src="https://absafricatv.com/wp-content/uploads/2026/07/Shailesh_Pednekar.jpg" alt="Shailesh Pednekar appointed COO – International Business at Bharat Serums and Vaccines”>
Shailesh Pednekar appointed COO – International Business at Bharat Serums and Vaccines
Divya Dhankhar joins Gilead Sciences as Director – Global Digital Innovation & AI
Dr. Srinivasa Rao Damma appointed General Manager at Vimta Labs
View More
Startup
SuperLiving raises $7 million in Series A to scale AI-powered preventive health platform
Lumos Health opens applications for second cohort of HealthTech and MedTech startups
Hoola Health raises $5 million to expand child-centric paediatric care
View More
Digitization
NHA integrates Google’s Gemma 4 AI into Aarogya Setu 2.0 to digitize health records
Govt includes vaccines, antimicrobials, NDPS and anti-cancer drugs under QR code authentication
AI moves from experimentation to enterprise tool across pharma value chain: GlobalData
View More
Upcoming E-conference
July 17, 2026
Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma
Latest Stories
Shailesh Pednekar appointed COO – International Business at Bharat Serums and Vaccines
Merck consolidates India tech operations under new Bengaluru GCC
ZeeLab Pharmacy launches iOS app to expand affordable digital healthcare access
Ambient clinical intelligence is reshaping future of healthcare delivery: Rustom Lawyer, Co-Founder & CEO, Augnito
EuroKids partners with Kauvery Hospitals to promote child health and early development
White Papers
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
Opinion
Ambient clinical intelligence is reshaping future of healthcare delivery: Rustom Lawyer, Co-Founder & CEO, Augnito
NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Interviews
Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head – API Regulatory Sciences, Biocon Limited
Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay VyasPresident and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International
Packaging
Clariant boosts high-speed packaging efficiency with expanded continuous strip desiccant reels
Coveris invests €1.8m in Poland to boost speed, capacity & packaging innovation
